PAVmed (PAVM) EBT Margin (2021 - 2025)
PAVmed's (PAVM) quarterly EBT Margin came in at 3403.7% in Q4 2025, down 1482370.0% year-on-year from N/an in Q4 2024, and up 97.17% quarter-over-quarter from 120220.0% in Q3 2025.
PAVmed (PAVM) EBT Margin (2021 - 2025) Analysis & Trends
PAVmed's EBT Margin history runs 5 years deep, the most recent figure standing at 3403.7% for Q4 2025.
- On a quarterly basis, EBT Margin fell 1482370.0% year-over-year to 3403.7% in Q4 2025; TTM through Dec 2025 was 2469.0%, a 83869.0% decrease from a year earlier, with the FY2025 full-year figure at 2469.0%, down 341815.0% from the prior year.
- EBT Margin climbed to 3403.7% in Q4 2025 per PAVM's latest filing, from 120220.0% in the prior quarter.
- Across five years, EBT Margin topped out at 232787.5% in Q1 2025 and bottomed at 205400.0% in Q2 2025.
- The 5-year median for EBT Margin is 5770.19% (2023), against an average of 12090.35%.
- Biggest YoY gain for EBT Margin was 23462037 bps in 2025; the steepest drop was 20387661 bps in 2025.
- Year by year, EBT Margin stood at 6559.67% in 2021, then slumped by 234 bps to 21939.29% in 2022, then soared by 92 bps to 1659.49% in 2023, then jumped by 788 bps to 11420.0% in 2024, then sank by 130 bps to 3403.7% in 2025.
- Per Business Quant, the three latest PAVM EBT Margin figures stand at 3403.7% (Q4 2025), 120220.0% (Q3 2025), and 205400.0% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 22.61% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.84% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 4.87% |
| 10 | PAVmed | 11.39 Mn | 9.86 Mn | -4,000.00 | -3,403.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,403.70% |
| Sep 30, 2025 | -120,220.00% |
| Jun 30, 2025 | -205,400.00% |
| Mar 31, 2025 | 232,787.50% |
| Dec 31, 2024 | 11,420.00% |
| Jun 30, 2024 | -1,523.39% |
| Mar 31, 2024 | -1,832.87% |
| Dec 31, 2023 | -1,659.49% |
| Sep 30, 2023 | -2,749.68% |
| Jun 30, 2023 | -10,778.31% |
| Mar 31, 2023 | -4,980.72% |
| Dec 31, 2022 | -21,939.29% |
| Sep 30, 2022 | -39,384.21% |
| Mar 31, 2022 | -10,387.83% |
| Dec 31, 2021 | -6,559.67% |
| Sep 30, 2021 | -6,834.00% |